Skip to Content


In the US, Bivalirudin (bivalirudin systemic) is a member of the drug class thrombin inhibitors and is used to treat Angina and Percutaneous Coronary Intervention.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Anticoagulant agent: Direct thrombin inhibitor

Chemical Names

D-Phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-calpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl-L-leucine (WHO)

H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH (WHO)

L-Leucine, D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl- (USAN)

Foreign Names

  • Bivalirudinum (Latin)
  • Bivalirudin (German)
  • Bivalirudine (French)
  • Bivalirudina (Spanish)

Generic Names

  • Bivalirudin (OS: USAN, BAN)
  • Bivalirudine (OS: DCF)
  • BG 8967 (IS)
  • UNII-TN9BEX005G (IS)

Brand Names

  • Angiomax
    Bagó, Argentina; Laboratorio Ferrer Chile, Chile; Medicines Company, Israel; Sunovion Pharmaceuticals, Canada; The Medicines Company, United States
  • Angiox
    Ferrer Internacional, Spain; The Medicines Co.-UK, Italy; The Medicines Company, Austria; The Medicines Company, Belgium; The Medicines Company, Germany; The Medicines Company, Denmark; The Medicines Company, Finland; The Medicines Company, Greece; The Medicines Company, Ireland; The Medicines Company, Iceland; The Medicines Company, Lithuania; The Medicines Company, Norway; The Medicines Company, Poland; The Medicines Company, Sweden; The Medicines Company UK, Cyprus; The Medicines Company UK, United Kingdom
  • Bivasave
    AHPL, India
  • Angiomax
    Healthcare Logistics, New Zealand
  • Angiox
    The Medicines Company, Switzerland


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.